Blood

Distinct roles for PARP-1 and PARP-2 in c-Myc-driven B-cell lymphoma in mice.

Galindo-Campos MA, Lutfi N, Bonnin S, ..., Sale JE, Yélamos J

Blood 139 (2) 228-239 [2022-01-13; online 2021-08-07]

Year 2021

A Novel CD34-Specific T-Cell Engager Efficiently Depletes Stem Cells and Acute Myeloid Leukemia Cells in Vitro and In Vivo

Arruda LCM, Jin L, Lambert M, ..., Carlsten M, Uhlin M

Blood 138 (Supplement 1) 2861-2861 [2021-11-05; online 2021-11-05]

Different Prognostic Impact of Recurrent Gene Mutations in IGHV-Mutated and IGHV-Unmutated Chronic Lymphocytic Leukemia: A Retrospective, Multi-Center Cohort Study By Eric, the European Research Initiative on CLL, in Harmony

Mansouri L, Thorvaldsdottir B, Sutton LA, ..., Stamatopoulos K, Rosenquist R

Blood 138 (Supplement 1) 2617-2617 [2021-11-05; online 2021-11-05]

Specific T Cell Receptor Gene Repertoire Profiles in Subgroups of CLL Patients with Distinct Genomic Aberrations

Vlachonikola E, Sofou E, Gkoliou G, ..., Baliakas P, Chatzidimitriou A

Blood 138 (Supplement 1) 3749-3749 [2021-11-05; online 2021-11-05]

Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL.

Agathangelidis A, Chatzidimitriou A, Gemenetzi K, ..., Ghia P, Stamatopoulos K

Blood 137 (10) 1365-1376 [2021-03-11; online 2020-09-30]

Year 2020

Association of aberrant ASNS imprinting with asparaginase sensitivity and chromosomal abnormality in childhood BCP-ALL.

Watanabe A, Miyake K, Nordlund J, ..., Sugita K, Inukai T

Blood 136 (20) 2319-2333 [2020-11-12; online 2020-06-24]

Proteogenomic Subtyping of Chronic Lymphocytic Leukemia Identifies a Novel Poor Outcome Subgroup with a Distinct Drug Response Profile

Herbst SA, Vesterlund M, Jafari R, ..., Lehtiö J, Dietrich S

Blood 136 (Supplement 1) 10-11 [2020-11-05; online 2020-11-05]

Prediction of Relapse after Allogeneic Stem Cell Transplantation Using Individualized Minimal Residual Markers; The Prospective Nordic Study NMDSG14B

Tobiasson M, Pandzic T, Illman J, ..., Dybedal I, Hellstrom Lindberg E

Blood 136 (Supplement 1) 5-6 [2020-11-05; online 2020-11-05]

Genomic and Transcriptomic Characterization of Adult and Pediatric Relapsed Acute Myeloid Leukemia Reveals Novel Therapeutic Targets

Stratmann S, Yones SA, Sun J, ..., Cavelier L, Holmfeldt L

Blood 136 (Supplement 1) 37-38 [2020-11-05; online 2020-11-05]

Lysine-specific demethylase 1A restricts ex vivo propagation of human HSCs and is a target of UM171.

Subramaniam A, Žemaitis K, Talkhoncheh MS, ..., Zubarev RA, Larsson J

Blood 136 (19) 2151-2161 [2020-11-05; online 2020-06-26]

Clonal Hematopoiesis Is Associated with Increased Risk for Therapy-Related Myeloid Neoplasms in Chronic Lymphocytic Leukemia Patients Treated with Chemo(immuno)Therapy

Voso MT, Pandzic T, Iskas M, ..., Fabiani E, Baliakas P

Blood 136 (Supplement 1) 19-20 [2020-11-05; online 2020-11-05]

High-parametric evaluation of human invariant natural killer T cells to delineate heterogeneity in allo- and autoimmunity.

Erkers T, Xie BJ, Kenyon LJ, ..., Maecker HT, Meyer EH

Blood 135 (11) 814-825 [2020-03-12; online 2020-01-15]

Year 2019

High-Throughput Functional Ex-Vivo Drug Testing and Multi-Omics Profiling in Patients with Acute Myeloid Leukemia

Erkers T, Seashore-Ludlow B, Struyf N, ..., Lehtiö J, Kallioniemi O

Blood 134 (Supplement_1) 4641-4641 [2019-11-13; online 2019-11-13]

Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact.

Baliakas P, Jeromin S, Iskas M, ..., Stamatopoulos K, ERIC, the European Research Initiative on CLL

Blood 133 (11) 1205-1216 [2019-03-14; online 2019-01-02]

Year 2018

A Proinflammatory Invariant Natural Killer T Cells Phenotypic State Associates with Human Graft-Versus-Host Disease Onset and Response

Erkers T, Xei B, Kenyon L, ..., Maecker HT, Meyer EH

Blood 132 (Supplement 1) 2111-2111 [2018-11-29; online 2018-11-29]

Comparative Analysis of Independent Ex Vivo functional Drug Screens Identifies Predictive Biomarkers of BCL-2 Inhibitor Response in AML

White BS, Khan SA, Ammad-ud-din M, ..., Wennerberg K, Guinney J

Blood 132 (Supplement 1) 2763-2763 [2018-11-29; online 2018-11-29]

Multi-Parametric Single Cell Profiling Defines Distinct Drug Responses in Healthy Hematological Cell Lineages That Are Retained in Corresponding Malignant Cell Types

Majumder MM, Leppä M, Hellesoy M, ..., Gjertsen B, Heckman CA

Blood 132 (Supplement 1) 264-264 [2018-11-29; online 2018-11-29]

Year 2017

KIT signaling is dispensable for human mast cell progenitor development.

Dahlin JS, Ekoff M, Grootens J, ..., Olsson-Strömberg U, Nilsson G

Blood 130 (16) 1785-1794 [2017-10-19; online 2017-08-08]

Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study.

Majeed A, Ågren A, Holmström M, ..., Frisk T, Schulman S

Blood 130 (15) 1706-1712 [2017-10-12; online 2017-08-23]

Ssb1 and Ssb2 cooperate to regulate mouse hematopoietic stem and progenitor cells by resolving replicative stress.

Shi W, Vu T, Boucher D, ..., Lane SW, Khanna KK

Blood 129 (18) 2479-2492 [2017-05-04; online 2017-03-07]

Year 2016

PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics study.

Bruzelius M, Iglesias MJ, Hong MG, ..., Trégouët DA, Odeberg J

Blood 128 (23) e59-e66 [2016-12-08; online 2016-10-14]

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma.

Mansouri L, Noerenberg D, Young E, ..., Rosenquist R, Damm F

Blood 128 (23) 2666-2670 [2016-12-08; online 2016-09-26]

Very Early Effects of Ibrutinib on Tumor and Immune Cells in Blood and Lymph Nodes in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) Patients

Palma M, Krstic A, Berglöf A, ..., Österborg A, Smith E

Blood 128 (22) 3235-3235 [2016-12-02; online 2016-12-02]

CD16-IL15-CD33 Trispecific Killer Engager (TriKE) Overcomes Cancer-Induced Immune Suppression and Induces Natural Killer Cell-Mediated Control of MDS and AML Via Enhanced Killing Kinetics

Felices M, Sarhan D, Brandt L, ..., Vallera D, Miller JS

Blood 128 (22) 4291-4291 [2016-12-02; online 2016-12-02]

Tailored Approaches for Refined Prognostication in Chronic Lymphocytic Leukemia Patients with Mutated Versus Unmutated Immunoglobulin Receptors

Baliakas P, Moysiadis T, Hadzidimitriou A, ..., Rosenquist R, Stamatopoulos, on behalf of ERIC K

Blood 128 (22) 3199-3199 [2016-12-02; online 2016-12-02]

Reappraising Immunoglobulin Repertoire Restrictions in Chronic Lymphocytic Leukemia: Focus on Major Stereotyped Subsets and Closely Related Satellites

Agathangelidis A, Hadzidimitriou A, Minga E, ..., Ghia P, Stamatopoulos K

Blood 128 (22) 4376-4376 [2016-12-02; online 2016-12-02]

The Heterogeneous Fusion Gene Landscape in Pediatric Acute Lymphoblastic Leukemia

Marincevic-Zuniga Y, Dahlberg J, Nilsson S, ..., Nordlund J, Syvänen AC

Blood 128 (22) 4081-4081 [2016-12-02; online 2016-12-02]

IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells.

Mao Y, van Hoef V, Zhang X, ..., Kiessling R, Lundqvist A

Blood 128 (11) 1475-1489 [2016-09-15; online 2016-07-27]

Affiliated researcher SciLifeLab Fellow Yumeng Mao

Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.

Ljungström V, Cortese D, Young E, ..., Sjöblom T, Rosenquist R

Blood 127 (8) 1007-1016 [2016-02-25; online 2015-12-16]

Year 2015

Identification and characterization of VEGF-A-responsive neutrophils expressing CD49d, VEGFR1, and CXCR4 in mice and humans.

Massena S, Christoffersson G, Vågesjö E, ..., Kreuger J, Phillipson M

Blood 126 (17) 2016-2026 [2015-10-22; online 2015-08-18]

Gustaf Christoffersson SciLifeLab Fellow

Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF.

Huffman JE, de Vries PS, Morrison AC, ..., O'Donnell CJ, Smith NL

Blood 126 (11) e19-e29 [2015-09-10; online 2015-06-23]

Prognostic relevance of MYD88 mutations in CLL: the jury is still out.

Baliakas P, Hadzidimitriou A, Agathangelidis A, ..., Ghia P, Rosenquist R

Blood 126 (8) 1043-1044 [2015-08-20; online 2015-08-22]

Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8.

Gounari M, Ntoufa S, Apollonio B, ..., Stamatopoulos K, Ghia P

Blood 125 (23) 3580-3587 [2015-06-04; online 2015-04-21]

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations.

Baliakas P, Agathangelidis A, Hadzidimitriou A, ..., Rosenquist R, Stamatopoulos K

Blood 125 (5) 856-859 [2015-01-29; online 2014-12-17]

Year 2013

Classification of human natural killer cells based on migration behavior and cytotoxic response.

Vanherberghen B, Olofsson PE, Forslund E, ..., Mehr R, Önfelt B

Blood 121 (8) 1326-1334 [2013-02-21; online 2013-01-03]

Intraperitoneal influx of neutrophils in response to IL-33 is mast cell-dependent.

Enoksson M, Möller-Westerberg C, Wicher G, ..., Lunderius-Andersson C, Nilsson G

Blood 121 (3) 530-536 [2013-01-17; online 2012-10-23]

Year 2012

Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation.

Huang J, Sabater-Lleal M, Asselbergs FW, ..., O'Donnell CJ, Hamsten A

Blood 120 (24) 4873-4881 [2012-12-06; online 2012-09-18]

VEGF-A recruits a proangiogenic MMP-9-delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissue.

Christoffersson G, Vågesjö E, Vandooren J, ..., Opdenakker G, Phillipson M

Blood 120 (23) 4653-4662 [2012-11-29; online 2012-09-10]

Gustaf Christoffersson SciLifeLab Fellow

Year 2010